Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

This study has been completed.
Information provided by:
Galderma Laboratories, L.P. Identifier:
First received: February 16, 2007
Last updated: April 3, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)